SHE:300841 Market Cap

SHE:300841 has a market cap or net worth of 7.48 billion as of April 29, 2026. Its market cap has decreased by -6.14% in one year.

Market Cap

7.48B

Enterprise Value

6.46B

Revenue

1.17B

Ranking

n/a

PE Ratio

41.16

Stock Price

57.60

Market Cap Chart

Since June 16, 2020, SHE:300841's market cap has increased from 6.08B to 7.48B, an increase of 23.11%. That is a compound annual growth rate of 3.61%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	7.36B	-21.63%
Dec 31, 2025	9.39B	34.30%
Dec 31, 2024	6.99B	-32.58%
Dec 29, 2023	10.37B	-8.37%
Dec 30, 2022	11.32B	-40.88%
Dec 31, 2021	19.14B	-31.86%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Aidea Pharmaceutical Group	7.43B
Acrobiosystems	7.74B
Nanjing Vazyme Biotech	7.74B
Suzhou Fengbei Biotech Stock	7.08B
Anhui Huaheng Biotechnology	6.99B
GemPharmatech	8.00B
Shanghai OPM Biosciences	6.94B
Daan Gene	8.10B

Market Cap Rankings